<?xml version="1.0" encoding='utf-8' ?>
<nspnews type="text">
<version>v8.0</version>
<date>2024-07-17 18:19:11</date>
<action>I</action>
<registdate>2024-07-17 17:57:46</registdate>
<modifydate>2024-07-17 18:01:21</modifydate>
<publishdate>2024-07-17 18:19:05</publishdate>
<embargo>N</embargo>
<newsid>708736</newsid>
<orgid></orgid>
<language>KR</language>
<category1>21</category1>
<category2>2102</category2>
<category1_name>의학/건강</category1_name>
<category2_name>제약/바이오</category2_name>
<statusID>1</statusID>
<saleID>N</saleID>
<formatID>1</formatID>
<typeID>9</typeID>
<newsSubject><![CDATA[[업앤다운]제약주 상승…서울제약 상한가·인벤티지랩↓]]></newsSubject>
<newsSummary><![CDATA[]]></newsSummary>
<newsTag><![CDATA[서울제약(018680),인벤티지랩(389470),제약주,코스피,코스닥]]></newsTag>
<newsLinks><![CDATA[]]></newsLinks>
<news_prolog><![CDATA[(서울=NSP통신) 이복현 기자 =]]></news_prolog>
<news1><![CDATA[17일 코스피(-0.80%)와 코스닥(-1.21%)이 모두 하락한 가운데 제약주(+1.94%)는 상승했다. 상승주는 108개였고 하락주는 57개였다.

오늘 제약주 중에서는 서울제약의 상승률이 가장 높았다. 서울제약은 전일대비 상한가(+30.00%, 1095원)를 기록하며 4745원에 장을 마감했다. 서울제약은 2거래일연속 상승세를 보이며 52주최고가(4745원)를 기록했다. 

또 샤페론(+29.94%) 지놈앤컴퍼니(+15.73%) 삼아제약(+14.01%) 모아라이프플러스(+11.97%) 안지오랩(+10.33%) 프레스티지바이오파마(+7.85%) 대원제약(+5.49%) 신신제약(+5.37%) 애드바이오텍(+4.20%) 등이 상승했다.

반면 인벤티지랩의 하락률이 높았다. 인벤티지랩은 전일대비 8.70%(1540원) 내려 1만6170원에 장을 마감했다. 인벤티지랩은 4거래일연속 하락세를 보였다. 

또 카이노스메드(-6.47%) 압타바이오(-6.13%) 드림씨아이에스(-5.24%) 옵투스제약(-4.93%) 녹십자웰빙(-4.65%) 브릿지바이오테라퓨틱스(-4.41%) 코오롱생명과학(-4.17%) 대화제약(-4.16%) 하이텍팜(-3.84%) 등이 하락했다.]]></news1>
<news2_title><![CDATA[]]></news2_title>
<news2><![CDATA[]]></news2>
<news3_title><![CDATA[]]></news3_title>
<news3><![CDATA[]]></news3>
<news4_title><![CDATA[]]></news4_title>
<news4><![CDATA[]]></news4>
<news5_title><![CDATA[]]></news5_title>
<news5><![CDATA[]]></news5>
<news_epilog_info><![CDATA[]]></news_epilog_info>
<news_epilog_byline><![CDATA[NSP통신 이복현 기자(bhlee2016@nspna.com)]]></news_epilog_byline>
<news_epilog><![CDATA[ⓒ한국의 경제뉴스통신사 NSP통신·NSP TV. 무단전재-재배포 및 AI학습 이용 금지.]]></news_epilog>
<imageL><![CDATA[https://file.nspna.com/news/2024/07/17/20240717175934_708736_0.jpg]]></imageL>
<imageP><![CDATA[https://file.nspna.com/news/2024/07/17/photo_20240717175934_708736_0.jpg]]></imageP>
<image1><![CDATA[https://file.nspna.com/news/2024/07/17/20240717175934_708736_1.jpg]]></image1>
<image2><![CDATA[]]></image2>
<image3><![CDATA[]]></image3>
<image4><![CDATA[]]></image4>
<image5><![CDATA[]]></image5>
<image1_place><![CDATA[l]]></image1_place>
<image2_place><![CDATA[c]]></image2_place>
<image3_place><![CDATA[c]]></image3_place>
<image4_place><![CDATA[c]]></image4_place>
<image5_place><![CDATA[c]]></image5_place>
<image1_text><![CDATA[]]></image1_text>
<image2_text><![CDATA[]]></image2_text>
<image3_text><![CDATA[]]></image3_text>
<image4_text><![CDATA[]]></image4_text>
<image5_text><![CDATA[]]></image5_text>
<image1_source><![CDATA[이미지 = 서울제약]]></image1_source>
<image2_source><![CDATA[]]></image2_source>
<image3_source><![CDATA[]]></image3_source>
<image4_source><![CDATA[]]></image4_source>
<image5_source><![CDATA[]]></image5_source>
<vodSite><![CDATA[]]></vodSite>
<vodID><![CDATA[]]></vodID>
<vodTitle><![CDATA[]]></vodTitle>
<vodWidth><![CDATA[]]></vodWidth>
<vodHeight><![CDATA[]]></vodHeight>
<advertorial><![CDATA[]]></advertorial>
<location><![CDATA[서울]]></location>
<teamID>107</teamID>
<teamName><![CDATA[의학건강부]]></teamName>
<writerID>bhlee2016</writerID>
<writerName><![CDATA[이복현]]></writerName>
<writerTitle><![CDATA[기자]]></writerTitle>
<writerEmail><![CDATA[bhlee2016@nspna.com]]></writerEmail>
<writerID2></writerID2>
<writerName2><![CDATA[]]></writerName2>
<writerTitle2><![CDATA[]]></writerTitle2>
<writerEmail2><![CDATA[]]></writerEmail2>
<writerID3></writerID3>
<writerName3><![CDATA[]]></writerName3>
<writerTitle3><![CDATA[]]></writerTitle3>
<writerEmail3><![CDATA[]]></writerEmail3>
</nspnews>
